Tibolone, Oral Estrogen-Progestin Therapy Linked to Risk for Heart Disease
THURSDAY, Dec. 5, 2024 (HealthDay News) -- Use of tibolone or oral estrogen-progestin therapy is associated with an increased risk for specific cardiovascular diseases, according to a study...